Transaction · 0001193125-26-388156
RVMDRevolution Medicines, Inc.
Kim Lorence H.
Kim Lorence H., DIR, reported an open-market or private sale at Revolution Medicines, Inc. involving 999.000000 shares for an estimated $207124.77. Reported holdings after the transaction were 15385.000000 shares. The stored filing text includes a detected 10b5-1 reference.
Open-market sellSEC transaction code SDIR
- Trade date
- Sep 08, 2026
- Filing date
- Sep 10, 2026
How reported position traded is calculated
Shares sold ÷ (holdings after + shares sold). Estimated position before: 16,384 shares.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
RVMD price since this filing
Daily closing prices, with the filing date and available return windowsRVMD · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +0.9%1w ago +4.9%1d ago +3.3%
Returns since7d -3.2%30d -6.7%90d180d1y
Transaction facts
Stored Form 4 columns with their raw values
- Type
- Sell Code S
- Identifier
- 0001193125-26-388156 Common Stock
- Transaction date
- Sep 08, 2026 Filed Sep 10, 2026, 09:52 PM · 2d delay
- Shares
- 999 sh $207.33 per share
- Estimated value
- -$207k Computed from shares × price
- Holdings after
- 15,385 sh Indirect · Trust
Filing signal explanations
Badges describe filing facts only — not predictions.
Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Repeat Seller 10b5-1 Detected
Filing-only score
-6 points
Compact filing score computed from stored Form 4 facts. Version v1.
Mixed or weak signal
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
How this score is calculated
- timely_filing+4 points
reporting_delay_days = 2
Filing reported within two business days of the transaction. - tenb5_1_detected-10 points
is_10b5_1 = true
Stored filing content includes detected 10b5-1 language.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Reported roles
No officer title
Officer NoDirector Yes10% NoOther No
Footnotes & amended
- F1
Includes 1,191 restricted stock units.
- F2
Transaction made pursuant to a 10b5-1 trading plan adopted by the Lorence Kim Revocable Trust on June 1, 2026.
- F3
The transaction was executed in multiple trades at prices ranging from $206.47 to $206.9903, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Per…
- F4
Shares held by the Lorence Kim Revocable Trust.
- F5
The transaction was executed in multiple trades at prices ranging from $207.02 to $207.70, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Perso…
- F6
The transaction was executed in multiple trades at prices ranging from $208.05 to $208.96, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Perso…
- F7
The transaction was executed in multiple trades at prices ranging from $209.08 to $209.9809, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Per…
- F8
The transaction was executed in multiple trades at prices ranging from $210.0114 to $210.97, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Per…
- F9
The transaction was executed in multiple trades at prices ranging from $211.00 to $211.9425, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Per…
- F10
The transaction was executed in multiple trades at prices ranging from $212.0775 to $212.3903, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting P…
Related transactions
Same SEC filing0 other transactions
Recent company activity
RVMD0 recent txs